Amifostine: Is there evidence of tumor protection?

被引：44
作者：
Koukourakis, MI [1 ]
机构：
[1] Democritus Univ Thrace, Dept Radiotherapy Oncol, Alexandroupolis, Greece
来源：
SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 06期
关键词：
D O I：
10.1053/j.seminoncol.2003.11.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：18 / 30
页数：13
相关论文
共 85 条
[1]  
ALBERTS DS, 1996, EUR J CANCER, V32, P17
[2]   Chemical radioprotection: A critical review of amifostine as a cytoprotector in radiotherapy [J].
Andreassen, CN ;
Gran, C ;
Lindegaard, JC .
SEMINARS IN RADIATION ONCOLOGY, 2003, 13 (01) :62-72
[3]   Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer [J].
Antonadou, D .
SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) :50-58
[4]   Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer [J].
Antonadou, D ;
Pepelassi, M ;
Synodinou, M ;
Puglisi, M ;
Throuvalas, N .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (03) :739-747
[5]   Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer [J].
Antonadou, D ;
Coliarakis, N ;
Synodinou, M ;
Athanassiou, H ;
Kouveli, A ;
Verigos, C ;
Georgakopoulos, G ;
Panoussaki, K ;
Karageorgis, P ;
Throuvalas, N .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (04) :915-922
[6]   Effects of amifostine on cisplatin induced DNA adduct formation and toxicity in malignant glioma and normal tissues in rat [J].
Bergström, P ;
Johnsson, A ;
Bergenheim, T ;
Henriksson, R .
JOURNAL OF NEURO-ONCOLOGY, 1999, 42 (01) :13-21
[7]   IMPROVEMENT IN RADIOTHERAPY FOR A MURINE SARCOMA BY INDOMETHACIN PLUS WR-2721 [J].
BESA, PC ;
HUNTER, NR ;
MILAS, L .
RADIATION RESEARCH, 1993, 135 (01) :93-97
[8]   Amifostine differentially modulates DNA damage evoked by idarubicin in normal and leukemic cells [J].
Blasiak, J ;
Gloc, E ;
Mlynarski, W ;
Drzewoski, J ;
Skórski, T .
LEUKEMIA RESEARCH, 2002, 26 (12) :1093-1096
[9]   Phase III randomized trial of amifostine as a radioprotector in head and neck cancer [J].
Brizel, DM ;
Wasserman, TH ;
Henke, M ;
Strnad, V ;
Rudat, V ;
Monnier, A ;
Eschwege, F ;
Zhang, J ;
Russell, L ;
Oster, W ;
Sauer, R .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) :3339-3345
[10]  
Budd GT, 1997, CANCER, V80, P1134
123456789